Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Other Working Capital Changes (2010 - 2023)

Nomad Power Solutions (NMAD) posted Other Working Capital Changes of -$21723.0 for Q3 2023, down 232.36% on a QoQ basis from -$6536.0 in Q2 2023, and down 30.82% year-over-year from -$31401.6 in Q3 2022.

Analysis

Nomad Power Solutions (NMAD) Other Working Capital Changes (2010 - 2023) Analysis & Trends

Nomad Power Solutions has reported Other Working Capital Changes for 14 years, with the latest figure at -$21723.0 in Q3 2023.

  • On a quarterly basis, Other Working Capital Changes fell 30.82% year-over-year to -$21723.0 in Q3 2023; TTM through Sep 2023 was $3883.0, a 146.97% increase from a year earlier, with the FY2022 full-year figure at $131.0, up 102.76% from the prior year.
  • Other Working Capital Changes was -$21723.0 for Q3 2023 at Nomad Power Solutions, down from -$6536.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $47500.0 in Q1 2021, with the low at -$21975.0 in Q4 2021.
  • Average Other Working Capital Changes over 5 years is -$72.53, with a median of -$6656.0 recorded in 2019.
  • The sharpest annual moves came in 2019 and 2021: Other Working Capital Changes tumbled 7373.75% in 2019, then jumped 997.07% in 2021.
  • Over 5 years, Other Working Capital Changes stood at -$8339.0 in 2019, then soared by 123.98% to $2000.0 in 2020, then tumbled by 1198.75% to -$21975.0 in 2021, then surged by 38.22% to -$13577.0 in 2022, then slumped by 60.0% to -$21723.0 in 2023.
  • The last three Other Working Capital Changes figures came in at -$21723.0 (Q3 2023), -$6536.0 (Q2 2023), and $45719.0 (Q1 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Nomad Power Solutions 49.59 Mn 49.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -21,723.00
Sep 30, 2023 -21,723.00
Jun 30, 2023 -6,536.00
Jun 30, 2023 -6,536.00
Mar 31, 2023 45,719.00
Mar 31, 2023 45,719.00
Dec 31, 2022 -13,577.00
Dec 31, 2022 -13,577.00
Sep 30, 2022 -16,605.00
Sep 30, 2022 -16,605.00
Jun 30, 2022 -11,357.00
Jun 30, 2022 -11,357.00
Mar 31, 2022 41,670.00
Mar 31, 2022 41,670.00
Dec 31, 2021 -21,975.00
Dec 31, 2021 -21,975.00
Sep 30, 2021 -12,647.00
Sep 30, 2021 -12,647.00
Jun 30, 2021 -17,629.00
Jun 30, 2021 -17,629.00